RB
Robert Burns HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
136
Avg Return
Past Year
Past Year
7.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
89.9%
Neutral
10.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $48 |
127%
upside
| 3 | +0.57% |
0
%
| 2 Jul ‘25 3 months ago |
|
|
|
Buy
Reiterated
| $12 |
419%
upside
| 3 | +5% |
0
%
| 16 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $72 |
35%
upside
| 4 | -0.6% |
0
%
| 14 May ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| $47 |
0%
upside
| 5 | +12% |
0
%
| 30 Apr ‘25 5 months ago |
|
|
|
Buy
Maintained
| $3 |
6%
upside
| 3 | +65% |
0
%
| 28 Apr ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $13 |
45%
upside
| 3 | +145% |
0
%
| 14 Apr ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $2 |
1%
downside
| 2 | – |
–
| 25 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $5 |
227%
upside
| 1 | +20% |
0
%
| 20 Mar ‘25 7 months ago |
|
|
|
Buy
Maintained
| $8 |
535%
upside
| 3 | -20% |
0
%
| 19 Mar ‘25 7 months ago |
|
|
|
Buy
Maintained
| $5 |
166%
upside
| 3 | -2.1% |
0
%
| 7 Mar ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -22% |
0
%
| 30 Jan ‘25 8 months ago |
|
|
|
Neutral
Reiterated
| – | – | 2 | – |
–
| 28 Jan ‘25 8 months ago |
|